Outpatient treatment (gentamicin injection and oral amoxicillin) for infants with a single low-mortality-risk PSBI sign was non-inferior to standard inpatient treatment, with significantly lower ...

In a clinical trial, six sessions of low-dose radiation significantly eased knee osteoarthritis pain and improved function for months afterwards, hinting at a safe, drug-free alternative for millions ...

A single course of low-dose radiation therapy may provide a safe and effective alternative treatment option for people with painful knee osteoarthritis according to a new randomized, ...

Low-dose aspirin significantly reduced colorectal cancer recurrence in patients with PI3K pathway gene alterations, nearly halving recurrence rates over three years compared to placebo. The study ...

A common over-the-counter medication could significantly reduce the risk of colorectal cancer coming back. In a Swedish study, a low dose of aspirin was shown to slash recurrence in half for patients ...

New research presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15–19 September) and published simultaneously in The Lancet shows that a ...

Please provide your email address to receive an email when new articles are posted on . A single dose of benzathine penicillin G is as effective against early syphilis as a three-dose regimen. The ...

Primary Mediastinal Germ Cell Tumors: A Real-World Analysis of Clinical Characteristics, Treatment, and Survival Outcomes From Two Tertiary Cancer Centers in India Abiraterone acetate (AA) is approved ...

Fentanyl, a powerful synthetic drug used for pain relief and anesthesia, has raised alarms in Costa Rica. It is about 100 times stronger than morphine and 50 times stronger than heroin, according to ...

Pfizer is taking a curtain call for Vyndaqel, the low-dose version of its blockbuster tafamidis franchise for the rare heart disease transthyretin amyloid cardiomyopathy (ATTR-CM). Pfizer will ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved gepotidacin (Blujepa, GSK), a new oral antibiotic for uncomplicated urinary tract infections (UTIs) in females aged 12 years ...